2
Clinical Trials associated with Salmonella paratyphi A conjugate vaccine(Lanzhou Institute of Biological Products) / Active, not recruitingPhase 3 评价甲型副伤寒结合疫苗在2-45岁健康人群中接种的安全性和流行病学保护效力的随机、盲法、阴性对照Ⅲ期临床试验
[Translation] A randomized, blinded, negative-controlled phase III clinical trial to evaluate the safety and epidemiological protective efficacy of paratyphoid A conjugate vaccine in healthy people aged 2-45 years
评价甲型副伤寒结合疫苗接种人体后对甲型副伤寒病的流行病学保护效力。
[Translation] To evaluate the epidemiological protective efficacy of paratyphoid A conjugate vaccine against paratyphoid A disease in humans.
评价甲型副伤寒结合疫苗在2岁以上人群接种的安全性及免疫原性II期临床试验
[Translation] Phase II clinical trial to evaluate the safety and immunogenicity of paratyphoid A conjugate vaccine in people over 2 years old
观察甲型副伤寒结合疫苗以不同剂量、不同免疫程序接种研究人群后的抗体水平,评价甲型副伤寒结合疫苗适宜的免疫剂量和免疫程序。评价不同剂量甲型副伤寒结合疫苗在研究人群中接种的安全性。评价甲型副伤寒结合疫苗接种后在不同年龄层人群中的免疫原性和安全性。
[Translation] To observe the antibody levels of the study population after different doses and different immunization schedules of Paratyphoid A conjugate vaccine, and to evaluate the appropriate immunization dose and immunization schedule of Paratyphoid A conjugate vaccine. To evaluate the safety of different doses of Paratyphoid A conjugate vaccine in the study population. To evaluate the immunogenicity and safety of Paratyphoid A conjugate vaccine in different age groups.
100 Clinical Results associated with Salmonella paratyphi A conjugate vaccine(Lanzhou Institute of Biological Products)
100 Translational Medicine associated with Salmonella paratyphi A conjugate vaccine(Lanzhou Institute of Biological Products)
100 Patents (Medical) associated with Salmonella paratyphi A conjugate vaccine(Lanzhou Institute of Biological Products)
100 Deals associated with Salmonella paratyphi A conjugate vaccine(Lanzhou Institute of Biological Products)